Search results for "Asthma"

showing 10 items of 860 documents

Sibship and Self-Esteem in Children With Asthma

2016

This study has explored the valence of sibship that may empower the self-esteem of children with asthma at the interpersonal, environmental control competence, emotionality management, and body-image levels. It has been assumed that the relationship between siblings may have a moderating effect on the negative impact that asthma has on child’s development. Seventy children suffering from chronic asthma have been involved: 40 children with siblings (experimental group) and 30 sibling-free children (control group). The children with asthma have exhibited higher levels of self-esteem in comparison with the sibling-free children. The results of the study, at the clinical significance level, hig…

Sibshipmedicine.medical_specialtymedia_common.quotation_subjectlcsh:MedicineInterpersonal communicationDevelopmentPediatricsArticle03 medical and health sciencesSettore M-PSI/04 - Psicologia Dello Sviluppo E Psicologia Dell'Educazione0302 clinical medicineChronic asthmaEmotionalitySelf-esteemmedicineClinical significance030212 general & internal medicineValence (psychology)PsychiatryChildrenAsthmamedia_commonbusiness.industrySelf-esteem; Sibship; Asthma; Children; Developmentlcsh:Rlcsh:RJ1-570Self-esteemlcsh:Pediatricsmedicine.diseaseAsthmarespiratory tract diseases030228 respiratory systembusinessself-esteem; sibship; asthma; children; developmentClinical psychologyPediatric Reports; Volume 8; Issue 2; Pages: 6370
researchProduct

Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study

2003

Objectives: Our objectives were to test the hypothesis that, in the geriatric population, chronic airway obstruction is associated with a higher prevalence of sleep disturbances; to identify the main correlates of sleep disturbances, and to verify whether asthma and COPD patients have different patterns of sleep disturbances. Methods: The EPESE questionnaire was administered to 734 patients aged 65 years and over with asthma or chronic obstructive pulmonary disease (cases) and 1237 individuals of comparable age who were free of respiratory disease but not of other chronic conditions (controls). Four sleep disturbances were quantified: difficulty in falling asleep, nocturnal awakening, morni…

Sleep Wake DisordersMalemedicine.medical_specialtyNeuropsychological TestsSettore MED/10 - Malattie Dell'Apparato RespiratorioLogistic regressionSeverity of Illness IndexCognition DisorderPulmonary Disease Chronic ObstructivePhysiology (medical)Internal medicineSurveys and QuestionnairesmedicineHumansSurveys and QuestionnaireSleep Wake DisorderWakefulnessDepression (differential diagnoses)Bronchodilator AgentAsthmaMorningAgedSleep disorderDepressive Disorder Majorbusiness.industryRespiratory diseasemedicine.diseaseSleep in non-human animalsBronchodilator AgentsSpirometryPhysical therapyGeriatric Depression ScaleFemaleNeuropsychological TestNeurology (clinical)businessCognition DisordersHuman
researchProduct

[Evolution over time in over perceivers of dyspnea in asthma].

2006

OBJECTIVE: In previous studies we identified a subgroup of patients whose perception of breathlessness was exaggerated during acute bronchoconstriction and who were termed “over perceivers” or “hyperperceivers.” In this study we aimed to determine whether such over perception is sporadic or stable over time. We also examined whether there is an association between over perception of dyspnea and hyperventilation syndrome. PATIENTS AND METHODS: The subjects were 22 stable asthmatics (11 men, 11 women) who had been over perceivers of dyspnea in a study 9 years earlier. After a medical history was taken, a patient performed forced spirometry and a severity classification was made according to t…

SpirometryAdultMalemedicine.medical_specialtyTime FactorsSeverity of Illness IndexHyperventilationmedicineHumansMedical historyAsthmaHyperventilation syndromemedicine.diagnostic_testbusiness.industryGeneral Medicinemedicine.diseaseAsthmarespiratory tract diseasesDyspneaBronchial hyperresponsivenessPhysical therapyAnxietyBronchoconstrictionFemalePerceptionmedicine.symptombusinessArchivos de bronconeumologia
researchProduct

[Perception of dyspnea and treatment adherence in asthmatic patients].

2008

OBJECTIVE: The majority of studies show that treatment adherence in chronic diseases such as asthma does not exceed 50%. Although the reasons may vary, it is clear that lack of treatment adherence is a determining factor in poor disease control. An association has also been observed between lack of perception of dyspnea and difficult-to-control asthma and with the occurrence of fatal or near-fatal asthma attacks. In this study we therefore attempted to demonstrate that one of the reasons that asthmatic patients do not adhere to treatment is a failure to perceive dyspnea associated with bronchial obstruction. PATIENTS AND METHODS: We analyzed 2 groups of patients with moderate persistent ast…

SpirometryAdultMalemedicine.medical_specialtyTreatment adherencemedia_common.quotation_subjectInternal medicinePerceptionmedicineAsthmatic patientHumansDepression (differential diagnoses)Asthmamedia_commonmedicine.diagnostic_testbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseDry-powder inhalerAsthmarespiratory tract diseasesDyspneaPhysical therapyAnxietyPatient ComplianceFemalemedicine.symptombusinessArchivos de bronconeumologia
researchProduct

Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study.

2019

Background: Prenatal exposure to perfluoroalkyl substances (PFASs) has been associated with impaired immune and respiratory health during childhood but the evidence is inconsistent and limited for lung function. We studied the association between prenatal PFASs exposure and immune and respiratory health, including lung function, up to age 7 years in the Spanish INMA birth cohort study. Methods: We assessed four PFASs in maternal plasma samples collected during the 1st trimester of pregnancy (years: 2003-2008): perfluorohexane sulfonate (PFHxS), perfluorooctane sulfonate (PFOS), perfluorooctanoate (PFOA), and perfluorononanoate (PFNA). Mothers reported the occurrence (yes/no) of lower respir…

SpirometryAdultVital capacityLongitudinal studyRespiratory diseasesEczemaPhysiology010501 environmental sciences01 natural sciences03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePregnancyMedicineHumans030212 general & internal medicineImmune responseChildMaternal-Fetal ExchangeRespiratory Tract Infections0105 earth and related environmental sciencesAsthmaRespiratory SoundsPregnancyFluorocarbonsRespiratory tract infectionsmedicine.diagnostic_testbusiness.industryPublic Health Environmental and Occupational HealthInfantPrenatal exposure delayed effectsmedicine.diseaseAsthmaRespiratory Function TestsPerfluorooctanePerfluoroalkyl substanceschemistryAlkanesulfonic AcidsMaternal ExposureSpainRelative riskChild PreschoolPrenatal Exposure Delayed EffectsEnvironmental PollutantsFemaleCaprylatesbusinessBirth cohortInternational journal of hygiene and environmental health
researchProduct

The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial.

2014

BackgroundTiotropium, a once-daily long-acting anticholinergic bronchodilator, has demonstrated efficacy in patients with asthma who were symptomatic despite treatment with medium- to high-dose inhaled corticosteroids (ICS).ObjectiveThe objective of this study was to evaluate the efficacy and safety of once-daily tiotropium Respimat (5 μg or 2.5 μg), compared with placebo Respimat, as add-on therapy to low- to medium-dose ICS for adults with symptomatic asthma.MethodsA phase III, double-blind, placebo-controlled trial was conducted (NCT01316380). Adults with symptomatic asthma receiving low- to medium-dose ICS (200-400 μg budesonide or equivalent dose) and a pre-bronchodilator forced expira…

SpirometryBudesonideAdultMaleRespimatmedicine.drug_classSymptomaticAnticholinergicMildPlacebo03 medical and health sciences0302 clinical medicineBronchodilatorsAdrenal Cortex HormonesBronchodilatorControlAdministration InhalationImmunology and AllergyMedicineHumans030212 general & internal medicineTiotropium BromideBudesonideAnticholinergic; Asthma; Bronchodilators; Control; GINA; ICS; Mild; Respimat; Symptomatic; Tiotropium; Administration Inhalation; Adrenal Cortex Hormones; Adult; Asthma; Bronchodilator Agents; Budesonide; Disease Progression; Drug Combinations; Female; Humans; Male; Placebo Effect; Spirometry; Tiotropium Bromide; Treatment Outcome; Immunology and AllergyAsthmamedicine.diagnostic_testbusiness.industryTiotropiumTiotropium bromidemedicine.diseasePlacebo EffectGINAAsthmarespiratory tract diseasesRespimatBronchodilator AgentsDrug CombinationsTreatment OutcomeInhalation030228 respiratory systemTolerabilityICSSpirometryAnesthesiaAdministrationDisease ProgressionFemalebusinessmedicine.drugThe journal of allergy and clinical immunology. In practice
researchProduct

Development of a nomogram to estimate the quality of life in asthmatic children using the Childhood Asthma Control Test

2016

Background: Pediatric Asthma Quality of Life Questionnaire (PAQLQ) provides detailed information on QoL in asthmatic children, whereas Childhood Asthma Control Test (C-ACT) Questionnaire is the most validated instrument for asthma control. No study assessed the relationship between C-ACT and QoL in children by means of those instruments. The aim of this study was to determine whether a QoL estimation is possible using the C-ACT questionnaire in asthmatic children. Methods: Medical history, spirometry, C-ACT, and PAQLQ were assessed in 144 (60% male) outpatient asthmatic children from September 2011 to November 2014. A generalized linear model (GLM) for the prediction of PAQLQ was obtained t…

SpirometryMalePediatricsmedicine.medical_specialtyPediatric Asthma Quality of Life QuestionnaireImmunologyPediatricsSeverity of Illness IndexChildhood Asthma Control Testnomogram03 medical and health sciencesFEV1/FVC ratio0302 clinical medicineQuality of lifechildren030225 pediatricsSurveys and QuestionnairesSeverity of illnessMedicineImmunology and AllergyHumansMedical historyPreschoolChildAsthmaChildhood asthmaasthma; Childhood Asthma Control Test; children; control; nomogram; Pediatric Asthma Quality of Life Questionnaire; Asthma; Child; Child Preschool; Female; Humans; Italy; Male; Pediatrics; Prognosis; Reproducibility of Results; Severity of Illness Index; Spirometry; Surveys and Questionnaires; Nomograms; Quality of Life; Pediatrics Perinatology and Child Health; Immunology and Allergy; Immunologymedicine.diagnostic_testbusiness.industryReproducibility of ResultsNomogramPerinatology and Child Healthasthmamedicine.diseasePrognosisNomograms030228 respiratory systemItalySpirometryChild PreschoolPediatrics Perinatology and Child HealthQuality of LifeFemaleasthma; Childhood Asthma Control Test; children; control; nomogram; Pediatric Asthma Quality of Life Questionnaire; Pediatrics Perinatology and Child Health; Immunology and Allergy; Immunologybusinesscontrol
researchProduct

A model-based approach for assessing bronchodilator responsiveness in children: The conventional cutoff revisited

2020

An increase in FEV1 >=12% has been proposed in international guidelines as a clue to airway reversibility for diagnosing asthma in both adults and children. However, the validity of this cut-off has been questioned in the pediatric population. The aim of this study was to provide evidence that different cut-off values in BDR may be associated with better performance in discriminating among outpatient children with naïve asthma (A) and without asthma (NA). We compared three approaches: i) the conventional cutoff (12%); ii) the cut-off estimated by Youden's criteria; and iii) the cut-off based on a model-driven approach. we found that the conventional cut-off of 12% showed poor sensitivity in…

SpirometryMalePediatricsmedicine.medical_specialtycut-offAdolescentmedicine.drug_classImmunologyspirometrySensitivity and Specificitysegmented modelchildrenReference ValuesBronchodilatorForced Expiratory VolumeImmunology and AllergyMedicineCutoffHumansChildAsthmaModels Statisticalmedicine.diagnostic_testbusiness.industryasthmachildren asthma spirometry bronchodilator response cut-offmedicine.diseaseBronchodilator AgentsChild PreschoolFemalebronchodilator responsedynamic nomogrambusiness
researchProduct

Determinants of Allergic Sensitization, Asthma and Lung Function: Results from a Cross-Sectional Study in Italian Schoolchildren

2020

Prenatal smoking exposure and early-life respiratory infections are major determinants of asthma during childhood. We investigate the factors influencing allergic sensitization (AS), asthma, and lung function in children and the balance between individual and environmental characteristics at different life stages. 1714 children aged 7&ndash

SpirometryMaleacute respiratory infectionsmedicine.medical_specialtyAdolescentCross-sectional studyHealth Toxicology and Mutagenesislcsh:Medicinecigarette smokingallergic sensitizationTobacco smokeArticleAllergic sensitization03 medical and health sciences0302 clinical medicinePregnancyRisk FactorsInternal medicineForced Expiratory VolumeMedicineHumans030212 general & internal medicineRespiratory systemChildLungLung functionAsthmaPregnancymedicine.diagnostic_testbusiness.industrylcsh:RPublic Health Environmental and Occupational Healthasthmamedicine.diseaserespiratory tract diseasesCross-Sectional Studies030228 respiratory systemItalySpirometryacute respiratory infectionchild healthFemaleTobacco Smoke Pollutionbusiness
researchProduct

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma

2021

AbstractSevere asthma is burdened by frequent exacerbations and use of oral corticosteroids (OCS), which worsen patients’ health and increase healthcare spending. The aim of this study was to assess the clinical and economic impact of switching from omalizumab (OMA) to mepolizumab (MEP) in patients eligible for both biologics, but not optimally controlled by omalizumab. We retrospectively enrolled uncontrolled severe asthmatic patients who switched from OMA to MEP during the last two years. Information included blood eosinophil count, asthma control test (ACT), spirometry, serum IgE, fractional exhaled nitric oxide (FeNO), OCS intake, drugs, exacerbations/hospitalizations, visits and diagno…

SpirometryMalemedicine.medical_specialtyExacerbationSciencehealth statusOmalizumabOmalizumabSettore MED/10 - Malattie Dell'Apparato RespiratorioAntibodies Monoclonal HumanizedArticlePulmonary function testing03 medical and health sciences0302 clinical medicinePharmacotherapyMedical researchInternal medicinemedicineHumansAnti-Asthmatic Agent030212 general & internal medicineAnti-Asthmatic AgentsPulmonary EosinophiliaAgedRetrospective StudiesRespiratory tract diseasesMultidisciplinarymedicine.diagnostic_testbusiness.industryQHealth careRHealth care economicsMiddle AgedAsthmaDiscontinuation030228 respiratory systemExhaled nitric oxideMedicineFemalebusinessMepolizumabmedicine.drugHumanScientific Reports
researchProduct